Anuh Pharma Ltd.

View in App
89.67 +0.09 ▲0.1%

06 June 2023, 04:01:00 PM
Volume: 21,578

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.anuhpharma.com
Market Cap 449.35 Cr.
Enterprise Value(EV) 442.70 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 7.22 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 12.42 Trailing Twelve Months Ending 2023-03
Industry PE 33.76 Trailing Twelve Months Ending 2023-03
Book Value / Share 48.14 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.86 Calculated using Price: 89.67
Dividend Yield 2.23 Period Ending 2022-03
No. of Shares Subscribed 5.01 Cr. 50,112,000 Shares
FaceValue 5
About Anuh Pharma Ltd.
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Anuh Pharma Ltd. Performance

View details >>
1 Day
+0.10%
1 Week
+1.57%
1 Month
+1.83%
3 Month
+6.53%
6 Month
-3.99%
1 Year
-3.79%
2 Year
-33.45%
5 Year
+17.55%
10 Year
+340.86%

Anuh Pharma Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.78 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11
Return on Capital Employed (%) 32.94 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33
Return on Assets (%) 11.75 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99

Anuh Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 86 101 119 141 150 165 162 191 214 241
Non Curr. Liab. 1 0 0 0 0 0 1 3 3 2
Curr. Liab. 77 67 72 47 59 75 163 139 131 161
Minority Int.
Equity & Liab. 163 168 191 187 208 239 326 333 347 404
Non Curr. Assets 22 24 40 50 54 87 103 95 88 97
Curr. Assets 142 144 151 138 154 152 223 238 259 308
Misc. Exp. not W/O
Total Assets 163 168 191 187 208 239 326 333 347 404

Anuh Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 266 284 326 206 238 321 307 432 487 527
Other Income 4 5 4 8 7 5 4 11 5 6
Total Income 271 289 330 214 245 325 311 443 492 534
Total Expenditure -242 -253 -289 -183 -220 -291 -284 -387 -439 -476
PBIDT 28 36 41 30 26 35 27 56 53 57
Interest -1 -1 -1 -1 0 -1 -1 -2 -2 0
Depreciation -2 -3 -2 -2 -2 -2 -7 -15 -12 -10
Taxation -8 -10 -12 -8 -7 -9 -5 -10 -9 -11
Exceptional Items
PAT 18 22 26 20 17 23 14 28 31 36
Adjusted EPS 4 4 5 4 3 5 3 6 6 7

Anuh Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 15 19 17 26 2 7 49 -19 29
Cash Fr. Inv. 4 -5 -12 -5 -20 2 3 -77 52 -8
Cash Fr. Finan. -6 -8 -8 -9 -4 -5 -7 22 -33 -19
Net Change 0 2 -1 2 2 -1 3 -5 0 2
Cash & Cash Eqvt 0 2 1 3 5 4 7 2 2 4

Anuh Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 70.47 70.43 70.43 70.45 70.43 70.58 70.58 70.58 70.58
Public 29.53 29.57 29.57 29.55 29.57 29.42 29.42 29.42 29.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Anuh Pharma Ltd. Announcements

View details >>
Sat, 03 Jun 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Dear Sir/Madam We are enclosing herewith our Companys Investor Presentation for the month of June 2023.Kindly take the same on record.
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for Financial Year ended 31/03/2023
Sat, 20 May 2023
Announcement under Regulation 30 (LODR)-Dividend Updates
Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Change in Director.

Anuh Pharma Ltd. Technical Scans

View details >>
Tue, 06 Jun 2023
High Delivery Percentage High Delivery Percentage
Closing Near 200 SMA Closing Near 200 SMA
Closing Near 20 SMA Closing Near 20 SMA
Mon, 05 Jun 2023
High Delivery Percentage High Delivery Percentage
Making Higher Highs for 3 days Making Higher Highs for 3 days

Anuh Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,184.60 1,013.55 +0.4%
Divi's Laboratories Ltd. 93,886.95 3,536.65 +2.2%
Cipla Ltd. 78,522.76 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. 77,195.89 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. 71,115.89 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. 60,794.95 1,796.30 +1.2%
Mankind Pharma Ltd. 59,699.70 1,490.30 +4.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.70 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 51.49 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 28.02 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.13 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.83 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.83 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 44.71 1,490.30 +4.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.34 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.35 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 3.35 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.32 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.49 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.81 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 5.75 1,490.30 +4.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 0.04 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,490.30 +4.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,490.30 +4.6%

Anuh Pharma Ltd. FAQ's

What is Anuh Pharma share price?
Can I buy Anuh Pharma shares now?
What is the Dividend Yield of Anuh Pharma?
What is the Market Cap of Anuh Pharma?
What are the key metrics to analyse Anuh Pharma?
What is the 52 Week High and Low of Anuh Pharma?
What is the trend of Anuh Pharma share price?